Objectives This study aimed to compare the consequences of angiotensin-converting-enzyme inhibitors
Objectives This study aimed to compare the consequences of angiotensin-converting-enzyme inhibitors (ACEis) and angiotensin receptor blockers (ARBs) on the chance of pneumonia and severe exacerbations in patients with COPD. for the sufferers getting ACEis and 0.52 per person-year for all those receiving ARBs. The sufferers receiving ACEis acquired a higher threat of serious exacerbations (aHR, … [Read more…]